These observations supported the contribution of PMA-induced activation of RSKs to the regulation of PDCD4 levels in these breast cancer cells, but not in cells with only the activating mutations in PI3K/Akt/mTORC1 pathway. This evidence concerns the gene AKT1 and breast carcinoma.